We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FEATURED ARTICLES

 

Latest Articles

Scientists Take Action To Stop Gender Inequality and Sexual Harassment in STEM
Article

In December 2018, a diverse group of scientific researchers gathered to challenge a key issue in the science, technology, Engineering and mathematics (STEM) workforce: gender bias, and sexual harassment. Now, the conclusions from the meeting have been eloquently described by 23 authors in an article published in the journal Science.

READ MORE

Vitamin B12 Deficiency: What is Pernicious Anaemia, and Why Can it Be so Dangerous?
Article

An estimated 6% of people in the US and UK suffer from vitamin B12 deficiency.

READ MORE

Are Automation and AI the Future of Brain Scan Analysis?
Article

The difficult part of looking inside the brain only starts after you leave the scanner. The error rate for image analysis remains alarmingly high, and radiologists are being asked to handle larger numbers of scans. Can automation lend a hand? We talked to Dr. Chris Airriess, CEO at CorTechs Labs Inc., which has developed a software designed to streamline the analysis pipeline.

READ MORE

Light and Sound Brain Wave Stimulation Shows Pre-clinical Potential As Alzheimer’s Therapy
Article

Research presented at Neuroscience 2019, hosted in Chicago this week, has shown promising pre-clinical data in mice that suggests altering the electrical oscillations of neuronal networks with external light and sound stimulation might have brain-boosting effects that reduce pathology related to Alzheimer’s disease (AD).

READ MORE

It’s Alive: Cautious Excitement Meets Claims of First Effective Alzheimer’s Drug
Article

American pharma giant Biogen has announced that its therapeutic compound for Alzheimer’s disease (AD), aducanumab, is to be taken to the FDA for approval. Despite being seemingly killed off after a study in March produced disappointing results, new analysis suggests that aducanumab met its target endpoints.

READ MORE

Merging With Machines: A Look at Emerging Neuroscience Technologies
Article

In this article, we explore how emerging neurotechnologies are taking us from movement-controlled to mind-controlled machines and from machine extensions of ourselves to machines integrated into ourselves.

READ MORE

Mouse Moms’ Microbiota Lead to Altered Behavior
Article

Research presented at Neuroscience 2019, the flagship conference of the Society for Neuroscience, has highlighted research at the intersection of three fascinating areas: neurodevelopment, the immune system and the gut microbiota.

READ MORE

Promises and Obstacles in Lipidomics Research
Article

A biomarker that represents the physiological environment of a cell at any given moment holds strong promise for quick and non-invasive diagnostics. The lipidome is gaining more traction among scientists in this field of research, and in this article, we explore why.

READ MORE

BNA Interview Series: Exploring the Inflamed Mind With Professor Ed Bullmore
Article

At the British Neuroscience Association's Festival of Neuroscience, we were lucky enough to sit down with some influential neuroscientists to discuss their work. In our last interview of the series, we talk to Professor Ed Bullmore on the evidence that connects inflammation and depression, and the possibility that the immune system could be targeted as part of future antidepressant treatments.

READ MORE

Who Is Responsible for Reproducible Science?
Article

Reproducibility is now recognized as a core feature of good scientific practice but too many papers fail to meet the grade. We talked to Leslie D McIntosh, CEO of Ripeta, on the topic of reproducibility. In this interview, we ask Leslie about the concepts within Ripeta’s recent report on the state of reproducible science in 2019.

READ MORE